Scapa Group plc announced three appointments to the Company's Board of Directors, with effect from 21 January 2019. Joe Doherty joins the Board as an Executive Director and the Company as Healthcare President-Designate. Joe will become Healthcare President on 1 April 2019 following Joe Davin's planned retirement on 31 March 2019. Joe's most recent role was President of Olympus Surgical Technologies America responsible for the strategic marketing, development and manufacturing of devices for a number of surgical specialties. He was also a member of the Olympus Corporation of the Americas Executive Committee. Sevan Demirdogen, current President and Executive Vice President of Scapa, joins the Board as an Executive Director. Sevan joined Scapa in April 2018 from Illinois Tool Works (ITW) where he held various roles since 1982. During the past 10 years, Sevan has been the Group President of ITW Stokvis. Juliet Thompson joins the Board as an Independent Non-Executive Director. Juliet will chair the Remuneration Committee and will also be a member of the Board's Audit and Risk, and Nomination Committees. Juliet is currently a board member of a number of internationally listed medical device, development and diagnostic companies, including being Non-Executive Director of Vectura Group plc, GI Dynamics Inc. and Novacyt SA, and Deputy Chairman of Nexstim plc. She was previously Non-Executive Chairman and Director of the Board of Premier Veterinary Group plc until 1 March 2018. Juliet has spent over 20 years actively involved in the life sciences sector working as an investment banker and strategic advisor to healthcare companies in Europe.